NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, News, & Analysis

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions declared that its board has initiated a stock repurchase plan on Thursday, August 2nd 2018, which permits the company to repurchase $250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 11.3% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its earnings results on Thursday, May, 2nd. The software maker reported $0.16 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.14 by $0.02. The software maker earned $432 million during the quarter, compared to the consensus estimate of $436.47 million. Allscripts Healthcare Solutions had a return on equity of 6.92% and a net margin of 20.60%. The firm's quarterly revenue was down .4% on a year-over-year basis. During the same period last year, the firm posted $0.16 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions updated its FY19 earnings guidance on Thursday, May, 2nd. The company provided earnings per share guidance of $0.65 to $0.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.67. Allscripts Healthcare Solutions also updated its FY 2019 guidance to $0.65-0.70 EPS.

9 analysts have issued 12-month target prices for Allscripts Healthcare Solutions' stock. Their predictions range from $10.00 to $16.00. On average, they expect Allscripts Healthcare Solutions' share price to reach $13.2857 in the next year. This suggests a possible upside of 26.2% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allscripts Healthcare Solutions.

Media stories about MDRX stock have trended somewhat negative on Tuesday, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of -1.2 on InfoTrie's scale. They also assigned media stories about the software maker a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future.

Allscripts Healthcare Solutions saw a increase in short interest in April. As of April 15th, there was short interest totalling 20,675,861 shares, an increase of 8.4% from the March 29th total of 19,078,421 shares. Based on an average daily volume of 1,566,012 shares, the short-interest ratio is currently 13.2 days. Approximately 12.4% of the company's shares are sold short. View Allscripts Healthcare Solutions' Current Options Chain.

Some companies that are related to Allscripts Healthcare Solutions include Caci International (CACI), Science Applications International (SAIC), Verint Systems (VRNT), NetScout Systems (NTCT), Scientific Games (SGMS), Ebix (EBIX), Nextgen Healthcare (NXGN), Sykes Enterprises (SYKE), Tufin Software Technologies (TUFN), Digimarc (DMRC), Onespan (OSPN), KEYW (KEYW), Ribbon Communications (RBBN), Pareteum (TEUM) and Agilysys (AGYS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Starbucks (SBUX), Walgreens Boots Alliance (WBA), Electronic Arts (EA), Nuance Communications (NUAN), AK Steel (AKS), Bausch Health Companies (BHC), Twitter (TWTR) and Autodesk (ADSK).

Allscripts Healthcare Solutions' stock is owned by many different of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (5.56%), Neuberger Berman Group LLC (1.88%), Northern Trust Corp (1.59%), Geode Capital Management LLC (1.56%), Fort Washington Investment Advisors Inc. OH (0.90%) and Jacobs Levy Equity Management Inc. (0.86%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

MDRX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Fort Washington Investment Advisors Inc. OH, Royce & Associates LP, Dimensional Fund Advisors LP, Marshall Wace LLP, BNP Paribas Arbitrage SA, Hennessy Advisors Inc. and Dupont Capital Management Corp. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, Dennis Olis and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

MDRX stock was purchased by a variety of institutional investors in the last quarter, including Alambic Investment Management L.P., Penn Capital Management Co. Inc., Man Group plc, Neuberger Berman Group LLC, GAM Holding AG, SEI Investments Co, Dynamic Technology Lab Private Ltd and Peregrine Capital Management LLC. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDRX stock can currently be purchased for approximately $10.53.

Allscripts Healthcare Solutions has a market capitalization of $1.75 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe.

The official website for Allscripts Healthcare Solutions is http://www.allscripts.com/.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]